{{Rsnum
|rsid=11738945
|Gene=ELL2
|Chromosome=5
|position=95926809
|Orientation=plus
|GMAF=0.2112
|Gene_s=ELL2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 67.7 | 26.2 | 6.2
| HCB | 45.5 | 38.6 | 15.9
| JPT | 62.2 | 31.1 | 6.7
| YRI | 98.4 | 1.6 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 45.5 | 38.6 | 15.9
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23382691
  |Trait=IgG glycosylation
  |Title=Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.
  |RiskAllele=C
  |Pval=1E-6
  |OR=.18
  |ORtxt=[0.11-0.25] unit increase
  |OA=1
}}